Over expression of RhoA is associated with progression in invasive breast duct carcinoma.
Ma
Li
L
Liu
Yue-ping
YP
Geng
Cui-zhi
CZ
Wang
Xiao-ling
XL
Wang
Yong-jun
YJ
Zhang
Xiang-hong
XH
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood / Q000235:genetics* / Q000401:mortality* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000097:blood / Q000235:genetics* / Q000401:mortality / Q000473:pathology / Q000556:secondary*; D015331:Cohort Studies; D018450:Disease Progression; D018572:Disease-Free Survival; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008207:Lymphatic Metastasis / Q000235:genetics; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000235:genetics* / Q000473:pathology; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D016019:Survival Analysis; D020742:rhoA GTP-Binding Protein / Q000097:blood*
D014408:Biomarkers, Tumor; D020742:rhoA GTP-Binding Protein